The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global CD38 Monoclonal Antibodies Market Research Report 2025
Synopsis
CD38 monoclonal antibodies target the CD38 surface antigen(sAg) of hematopoietic cells, which is important for cell function. Once CD38 monoclonal antibodies bind to the antigen it inhibits tumour growth by interrupting CD38 functions and causes cell death. CD38 monoclonal antibodies are used to treat multiple myeloma.
The global CD38 Monoclonal Antibodies market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for CD38 Monoclonal Antibodies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for CD38 Monoclonal Antibodies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of CD38 Monoclonal Antibodies include Johnson & Johnson, Sanofi, Janssen Biotech, Carbosynth, Creative Biolabs and BOC Sciences, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for CD38 Monoclonal Antibodies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CD38 Monoclonal Antibodies.
Report Scope
The CD38 Monoclonal Antibodies market size, estimations, and forecasts are provided in terms of sales volume (Liter) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global CD38 Monoclonal Antibodies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CD38 Monoclonal Antibodies manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson
Sanofi
Janssen Biotech
Carbosynth
Creative Biolabs
BOC Sciences
Segment by Type
Daratumumab
Isatuximab
Segment by Application
Pharmacy
Laboratory Use
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of CD38 Monoclonal Antibodies manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of CD38 Monoclonal Antibodies in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
CD38 monoclonal antibodies target the CD38 surface antigen(sAg) of hematopoietic cells, which is important for cell function. Once CD38 monoclonal antibodies bind to the antigen it inhibits tumour growth by interrupting CD38 functions and causes cell death. CD38 monoclonal antibodies are used to treat multiple myeloma.
The global CD38 Monoclonal Antibodies market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for CD38 Monoclonal Antibodies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for CD38 Monoclonal Antibodies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of CD38 Monoclonal Antibodies include Johnson & Johnson, Sanofi, Janssen Biotech, Carbosynth, Creative Biolabs and BOC Sciences, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for CD38 Monoclonal Antibodies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CD38 Monoclonal Antibodies.
Report Scope
The CD38 Monoclonal Antibodies market size, estimations, and forecasts are provided in terms of sales volume (Liter) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global CD38 Monoclonal Antibodies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CD38 Monoclonal Antibodies manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson
Sanofi
Janssen Biotech
Carbosynth
Creative Biolabs
BOC Sciences
Segment by Type
Daratumumab
Isatuximab
Segment by Application
Pharmacy
Laboratory Use
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of CD38 Monoclonal Antibodies manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of CD38 Monoclonal Antibodies in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 CD38 Monoclonal Antibodies Market Overview
1.1 Product Overview and Scope of CD38 Monoclonal Antibodies
1.2 CD38 Monoclonal Antibodies Segment by Type
1.2.1 Global CD38 Monoclonal Antibodies Market Value Comparison by Type (2024-2030)
1.2.2 Daratumumab
1.2.3 Isatuximab
1.3 CD38 Monoclonal Antibodies Segment by Application
1.3.1 Global CD38 Monoclonal Antibodies Market Value by Application: (2024-2030)
1.3.2 Pharmacy
1.3.3 Laboratory Use
1.4 Global CD38 Monoclonal Antibodies Market Size Estimates and Forecasts
1.4.1 Global CD38 Monoclonal Antibodies Revenue 2019-2030
1.4.2 Global CD38 Monoclonal Antibodies Sales 2019-2030
1.4.3 Global CD38 Monoclonal Antibodies Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 CD38 Monoclonal Antibodies Market Competition by Manufacturers
2.1 Global CD38 Monoclonal Antibodies Sales Market Share by Manufacturers (2019-2024)
2.2 Global CD38 Monoclonal Antibodies Revenue Market Share by Manufacturers (2019-2024)
2.3 Global CD38 Monoclonal Antibodies Average Price by Manufacturers (2019-2024)
2.4 Global CD38 Monoclonal Antibodies Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of CD38 Monoclonal Antibodies, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of CD38 Monoclonal Antibodies, Product Type & Application
2.7 CD38 Monoclonal Antibodies Market Competitive Situation and Trends
2.7.1 CD38 Monoclonal Antibodies Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest CD38 Monoclonal Antibodies Players Market Share by Revenue
2.7.3 Global CD38 Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 CD38 Monoclonal Antibodies Retrospective Market Scenario by Region
3.1 Global CD38 Monoclonal Antibodies Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global CD38 Monoclonal Antibodies Global CD38 Monoclonal Antibodies Sales by Region: 2019-2030
3.2.1 Global CD38 Monoclonal Antibodies Sales by Region: 2019-2024
3.2.2 Global CD38 Monoclonal Antibodies Sales by Region: 2025-2030
3.3 Global CD38 Monoclonal Antibodies Global CD38 Monoclonal Antibodies Revenue by Region: 2019-2030
3.3.1 Global CD38 Monoclonal Antibodies Revenue by Region: 2019-2024
3.3.2 Global CD38 Monoclonal Antibodies Revenue by Region: 2025-2030
3.4 North America CD38 Monoclonal Antibodies Market Facts & Figures by Country
3.4.1 North America CD38 Monoclonal Antibodies Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America CD38 Monoclonal Antibodies Sales by Country (2019-2030)
3.4.3 North America CD38 Monoclonal Antibodies Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe CD38 Monoclonal Antibodies Market Facts & Figures by Country
3.5.1 Europe CD38 Monoclonal Antibodies Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe CD38 Monoclonal Antibodies Sales by Country (2019-2030)
3.5.3 Europe CD38 Monoclonal Antibodies Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific CD38 Monoclonal Antibodies Market Facts & Figures by Country
3.6.1 Asia Pacific CD38 Monoclonal Antibodies Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific CD38 Monoclonal Antibodies Sales by Country (2019-2030)
3.6.3 Asia Pacific CD38 Monoclonal Antibodies Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America CD38 Monoclonal Antibodies Market Facts & Figures by Country
3.7.1 Latin America CD38 Monoclonal Antibodies Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America CD38 Monoclonal Antibodies Sales by Country (2019-2030)
3.7.3 Latin America CD38 Monoclonal Antibodies Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa CD38 Monoclonal Antibodies Market Facts & Figures by Country
3.8.1 Middle East and Africa CD38 Monoclonal Antibodies Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa CD38 Monoclonal Antibodies Sales by Country (2019-2030)
3.8.3 Middle East and Africa CD38 Monoclonal Antibodies Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global CD38 Monoclonal Antibodies Sales by Type (2019-2030)
4.1.1 Global CD38 Monoclonal Antibodies Sales by Type (2019-2024)
4.1.2 Global CD38 Monoclonal Antibodies Sales by Type (2025-2030)
4.1.3 Global CD38 Monoclonal Antibodies Sales Market Share by Type (2019-2030)
4.2 Global CD38 Monoclonal Antibodies Revenue by Type (2019-2030)
4.2.1 Global CD38 Monoclonal Antibodies Revenue by Type (2019-2024)
4.2.2 Global CD38 Monoclonal Antibodies Revenue by Type (2025-2030)
4.2.3 Global CD38 Monoclonal Antibodies Revenue Market Share by Type (2019-2030)
4.3 Global CD38 Monoclonal Antibodies Price by Type (2019-2030)
5 Segment by Application
5.1 Global CD38 Monoclonal Antibodies Sales by Application (2019-2030)
5.1.1 Global CD38 Monoclonal Antibodies Sales by Application (2019-2024)
5.1.2 Global CD38 Monoclonal Antibodies Sales by Application (2025-2030)
5.1.3 Global CD38 Monoclonal Antibodies Sales Market Share by Application (2019-2030)
5.2 Global CD38 Monoclonal Antibodies Revenue by Application (2019-2030)
5.2.1 Global CD38 Monoclonal Antibodies Revenue by Application (2019-2024)
5.2.2 Global CD38 Monoclonal Antibodies Revenue by Application (2025-2030)
5.2.3 Global CD38 Monoclonal Antibodies Revenue Market Share by Application (2019-2030)
5.3 Global CD38 Monoclonal Antibodies Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Corporation Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson CD38 Monoclonal Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Johnson & Johnson CD38 Monoclonal Antibodies Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Corporation Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi CD38 Monoclonal Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi CD38 Monoclonal Antibodies Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 Janssen Biotech
6.3.1 Janssen Biotech Corporation Information
6.3.2 Janssen Biotech Description and Business Overview
6.3.3 Janssen Biotech CD38 Monoclonal Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Janssen Biotech CD38 Monoclonal Antibodies Product Portfolio
6.3.5 Janssen Biotech Recent Developments/Updates
6.4 Carbosynth
6.4.1 Carbosynth Corporation Information
6.4.2 Carbosynth Description and Business Overview
6.4.3 Carbosynth CD38 Monoclonal Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Carbosynth CD38 Monoclonal Antibodies Product Portfolio
6.4.5 Carbosynth Recent Developments/Updates
6.5 Creative Biolabs
6.5.1 Creative Biolabs Corporation Information
6.5.2 Creative Biolabs Description and Business Overview
6.5.3 Creative Biolabs CD38 Monoclonal Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Creative Biolabs CD38 Monoclonal Antibodies Product Portfolio
6.5.5 Creative Biolabs Recent Developments/Updates
6.6 BOC Sciences
6.6.1 BOC Sciences Corporation Information
6.6.2 BOC Sciences Description and Business Overview
6.6.3 BOC Sciences CD38 Monoclonal Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.6.4 BOC Sciences CD38 Monoclonal Antibodies Product Portfolio
6.6.5 BOC Sciences Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 CD38 Monoclonal Antibodies Industry Chain Analysis
7.2 CD38 Monoclonal Antibodies Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 CD38 Monoclonal Antibodies Production Mode & Process
7.4 CD38 Monoclonal Antibodies Sales and Marketing
7.4.1 CD38 Monoclonal Antibodies Sales Channels
7.4.2 CD38 Monoclonal Antibodies Distributors
7.5 CD38 Monoclonal Antibodies Customers
8 CD38 Monoclonal Antibodies Market Dynamics
8.1 CD38 Monoclonal Antibodies Industry Trends
8.2 CD38 Monoclonal Antibodies Market Drivers
8.3 CD38 Monoclonal Antibodies Market Challenges
8.4 CD38 Monoclonal Antibodies Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global CD38 Monoclonal Antibodies Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global CD38 Monoclonal Antibodies Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global CD38 Monoclonal Antibodies Market Competitive Situation by Manufacturers in 2023
Table 4. Global CD38 Monoclonal Antibodies Sales (Liter) of Key Manufacturers (2019-2024)
Table 5. Global CD38 Monoclonal Antibodies Sales Market Share by Manufacturers (2019-2024)
Table 6. Global CD38 Monoclonal Antibodies Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global CD38 Monoclonal Antibodies Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market CD38 Monoclonal Antibodies Average Price (US$/ml) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of CD38 Monoclonal Antibodies, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of CD38 Monoclonal Antibodies, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of CD38 Monoclonal Antibodies, Product Type & Application
Table 12. Global Key Manufacturers of CD38 Monoclonal Antibodies, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global CD38 Monoclonal Antibodies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD38 Monoclonal Antibodies as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global CD38 Monoclonal Antibodies Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global CD38 Monoclonal Antibodies Sales by Region (2019-2024) & (Liter)
Table 18. Global CD38 Monoclonal Antibodies Sales Market Share by Region (2019-2024)
Table 19. Global CD38 Monoclonal Antibodies Sales by Region (2025-2030) & (Liter)
Table 20. Global CD38 Monoclonal Antibodies Sales Market Share by Region (2025-2030)
Table 21. Global CD38 Monoclonal Antibodies Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global CD38 Monoclonal Antibodies Revenue Market Share by Region (2019-2024)
Table 23. Global CD38 Monoclonal Antibodies Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global CD38 Monoclonal Antibodies Revenue Market Share by Region (2025-2030)
Table 25. North America CD38 Monoclonal Antibodies Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America CD38 Monoclonal Antibodies Sales by Country (2019-2024) & (Liter)
Table 27. North America CD38 Monoclonal Antibodies Sales by Country (2025-2030) & (Liter)
Table 28. North America CD38 Monoclonal Antibodies Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America CD38 Monoclonal Antibodies Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe CD38 Monoclonal Antibodies Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe CD38 Monoclonal Antibodies Sales by Country (2019-2024) & (Liter)
Table 32. Europe CD38 Monoclonal Antibodies Sales by Country (2025-2030) & (Liter)
Table 33. Europe CD38 Monoclonal Antibodies Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe CD38 Monoclonal Antibodies Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific CD38 Monoclonal Antibodies Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific CD38 Monoclonal Antibodies Sales by Region (2019-2024) & (Liter)
Table 37. Asia Pacific CD38 Monoclonal Antibodies Sales by Region (2025-2030) & (Liter)
Table 38. Asia Pacific CD38 Monoclonal Antibodies Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific CD38 Monoclonal Antibodies Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America CD38 Monoclonal Antibodies Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America CD38 Monoclonal Antibodies Sales by Country (2019-2024) & (Liter)
Table 42. Latin America CD38 Monoclonal Antibodies Sales by Country (2025-2030) & (Liter)
Table 43. Latin America CD38 Monoclonal Antibodies Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America CD38 Monoclonal Antibodies Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa CD38 Monoclonal Antibodies Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa CD38 Monoclonal Antibodies Sales by Country (2019-2024) & (Liter)
Table 47. Middle East & Africa CD38 Monoclonal Antibodies Sales by Country (2025-2030) & (Liter)
Table 48. Middle East & Africa CD38 Monoclonal Antibodies Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa CD38 Monoclonal Antibodies Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global CD38 Monoclonal Antibodies Sales (Liter) by Type (2019-2024)
Table 51. Global CD38 Monoclonal Antibodies Sales (Liter) by Type (2025-2030)
Table 52. Global CD38 Monoclonal Antibodies Sales Market Share by Type (2019-2024)
Table 53. Global CD38 Monoclonal Antibodies Sales Market Share by Type (2025-2030)
Table 54. Global CD38 Monoclonal Antibodies Revenue (US$ Million) by Type (2019-2024)
Table 55. Global CD38 Monoclonal Antibodies Revenue (US$ Million) by Type (2025-2030)
Table 56. Global CD38 Monoclonal Antibodies Revenue Market Share by Type (2019-2024)
Table 57. Global CD38 Monoclonal Antibodies Revenue Market Share by Type (2025-2030)
Table 58. Global CD38 Monoclonal Antibodies Price (US$/ml) by Type (2019-2024)
Table 59. Global CD38 Monoclonal Antibodies Price (US$/ml) by Type (2025-2030)
Table 60. Global CD38 Monoclonal Antibodies Sales (Liter) by Application (2019-2024)
Table 61. Global CD38 Monoclonal Antibodies Sales (Liter) by Application (2025-2030)
Table 62. Global CD38 Monoclonal Antibodies Sales Market Share by Application (2019-2024)
Table 63. Global CD38 Monoclonal Antibodies Sales Market Share by Application (2025-2030)
Table 64. Global CD38 Monoclonal Antibodies Revenue (US$ Million) by Application (2019-2024)
Table 65. Global CD38 Monoclonal Antibodies Revenue (US$ Million) by Application (2025-2030)
Table 66. Global CD38 Monoclonal Antibodies Revenue Market Share by Application (2019-2024)
Table 67. Global CD38 Monoclonal Antibodies Revenue Market Share by Application (2025-2030)
Table 68. Global CD38 Monoclonal Antibodies Price (US$/ml) by Application (2019-2024)
Table 69. Global CD38 Monoclonal Antibodies Price (US$/ml) by Application (2025-2030)
Table 70. Johnson & Johnson Corporation Information
Table 71. Johnson & Johnson Description and Business Overview
Table 72. Johnson & Johnson CD38 Monoclonal Antibodies Sales (Liter), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2019-2024)
Table 73. Johnson & Johnson CD38 Monoclonal Antibodies Product
Table 74. Johnson & Johnson Recent Developments/Updates
Table 75. Sanofi Corporation Information
Table 76. Sanofi Description and Business Overview
Table 77. Sanofi CD38 Monoclonal Antibodies Sales (Liter), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2019-2024)
Table 78. Sanofi CD38 Monoclonal Antibodies Product
Table 79. Sanofi Recent Developments/Updates
Table 80. Janssen Biotech Corporation Information
Table 81. Janssen Biotech Description and Business Overview
Table 82. Janssen Biotech CD38 Monoclonal Antibodies Sales (Liter), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2019-2024)
Table 83. Janssen Biotech CD38 Monoclonal Antibodies Product
Table 84. Janssen Biotech Recent Developments/Updates
Table 85. Carbosynth Corporation Information
Table 86. Carbosynth Description and Business Overview
Table 87. Carbosynth CD38 Monoclonal Antibodies Sales (Liter), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2019-2024)
Table 88. Carbosynth CD38 Monoclonal Antibodies Product
Table 89. Carbosynth Recent Developments/Updates
Table 90. Creative Biolabs Corporation Information
Table 91. Creative Biolabs Description and Business Overview
Table 92. Creative Biolabs CD38 Monoclonal Antibodies Sales (Liter), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2019-2024)
Table 93. Creative Biolabs CD38 Monoclonal Antibodies Product
Table 94. Creative Biolabs Recent Developments/Updates
Table 95. BOC Sciences Corporation Information
Table 96. BOC Sciences Description and Business Overview
Table 97. BOC Sciences CD38 Monoclonal Antibodies Sales (Liter), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2019-2024)
Table 98. BOC Sciences CD38 Monoclonal Antibodies Product
Table 99. BOC Sciences Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. CD38 Monoclonal Antibodies Distributors List
Table 103. CD38 Monoclonal Antibodies Customers List
Table 104. CD38 Monoclonal Antibodies Market Trends
Table 105. CD38 Monoclonal Antibodies Market Drivers
Table 106. CD38 Monoclonal Antibodies Market Challenges
Table 107. CD38 Monoclonal Antibodies Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of CD38 Monoclonal Antibodies
Figure 2. Global CD38 Monoclonal Antibodies Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global CD38 Monoclonal Antibodies Market Share by Type in 2023 & 2030
Figure 4. Daratumumab Product Picture
Figure 5. Isatuximab Product Picture
Figure 6. Global CD38 Monoclonal Antibodies Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global CD38 Monoclonal Antibodies Market Share by Application in 2023 & 2030
Figure 8. Pharmacy
Figure 9. Laboratory Use
Figure 10. Global CD38 Monoclonal Antibodies Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global CD38 Monoclonal Antibodies Market Size (2019-2030) & (US$ Million)
Figure 12. Global CD38 Monoclonal Antibodies Sales (2019-2030) & (Liter)
Figure 13. Global CD38 Monoclonal Antibodies Average Price (US$/ml) & (2019-2030)
Figure 14. CD38 Monoclonal Antibodies Report Years Considered
Figure 15. CD38 Monoclonal Antibodies Sales Share by Manufacturers in 2023
Figure 16. Global CD38 Monoclonal Antibodies Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest CD38 Monoclonal Antibodies Players: Market Share by Revenue in 2023
Figure 18. CD38 Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global CD38 Monoclonal Antibodies Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America CD38 Monoclonal Antibodies Sales Market Share by Country (2019-2030)
Figure 21. North America CD38 Monoclonal Antibodies Revenue Market Share by Country (2019-2030)
Figure 22. U.S. CD38 Monoclonal Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada CD38 Monoclonal Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe CD38 Monoclonal Antibodies Sales Market Share by Country (2019-2030)
Figure 25. Europe CD38 Monoclonal Antibodies Revenue Market Share by Country (2019-2030)
Figure 26. Germany CD38 Monoclonal Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France CD38 Monoclonal Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. CD38 Monoclonal Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy CD38 Monoclonal Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia CD38 Monoclonal Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific CD38 Monoclonal Antibodies Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific CD38 Monoclonal Antibodies Revenue Market Share by Region (2019-2030)
Figure 33. China CD38 Monoclonal Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan CD38 Monoclonal Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea CD38 Monoclonal Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India CD38 Monoclonal Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia CD38 Monoclonal Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Taiwan CD38 Monoclonal Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia CD38 Monoclonal Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand CD38 Monoclonal Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia CD38 Monoclonal Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Philippines CD38 Monoclonal Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America CD38 Monoclonal Antibodies Sales Market Share by Country (2019-2030)
Figure 44. Latin America CD38 Monoclonal Antibodies Revenue Market Share by Country (2019-2030)
Figure 45. Mexico CD38 Monoclonal Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil CD38 Monoclonal Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina CD38 Monoclonal Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa CD38 Monoclonal Antibodies Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa CD38 Monoclonal Antibodies Revenue Market Share by Country (2019-2030)
Figure 50. Turkey CD38 Monoclonal Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia CD38 Monoclonal Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE CD38 Monoclonal Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of CD38 Monoclonal Antibodies by Type (2019-2030)
Figure 54. Global Revenue Market Share of CD38 Monoclonal Antibodies by Type (2019-2030)
Figure 55. Global CD38 Monoclonal Antibodies Price (US$/ml) by Type (2019-2030)
Figure 56. Global Sales Market Share of CD38 Monoclonal Antibodies by Application (2019-2030)
Figure 57. Global Revenue Market Share of CD38 Monoclonal Antibodies by Application (2019-2030)
Figure 58. Global CD38 Monoclonal Antibodies Price (US$/ml) by Application (2019-2030)
Figure 59. CD38 Monoclonal Antibodies Value Chain
Figure 60. CD38 Monoclonal Antibodies Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
